Advertisement
Screener

EMBECTA CORP. (EMBC) ROI

Embecta Corp. ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Embecta Corp. roi for the quarter ending 2026-06-30 was 10.39%, a 0.76% decline year-over-year.
  • Embecta Corp. roi for the quarter ending 2026-03-31 was 15.98%, a 136.78% increase year-over-year.
  • Embecta Corp. roi for the quarter ending 2025-12-31 was 18.62%, a 148.04% increase year-over-year.
  • Embecta Corp. roi for the quarter ending 2025-09-30 was 12.76%, a 36.33% increase year-over-year.
  • Embecta Corp. roi for fiscal 2025 was 12.76%, a 36.33% increase from fiscal 2024.
  • Embecta Corp. roi for fiscal 2024 was 9.36%, a 3.94% increase from fiscal 2023.
  • Embecta Corp. roi for fiscal 2023 was 9.01%, a 71.15% decline from fiscal 2022.
  • Embecta Corp. roi for fiscal 2022 was 31.22%, a 55.27% decline from fiscal 2021.
Available history
2021-09-30 to 2026-06-30
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2026-06-3010.39%$87.5M$21.10M$842.4M
2026-03-3115.98%$111.9M-$4.10M$700.3M
2025-12-3118.62%$139.5M$44.10M$749.3M
2025-09-3012.76%$95.4M$26.40M$747.6M
2025-06-3010.47%$83.6M$45.50M$798.7M
2025-03-316.75%$52.8M$23.50M$782.4M
2024-12-317.51%$58.2M$0.00$775.4M
2024-09-309.36%$78.3M$14.60M$836.5M
2024-06-308.33%$69.7M$14.70M$836.6M
2024-03-318.44%$70.2M$28.90M$831.7M
2023-12-316.84%$55.3M$20.10M$808.9M
2023-09-309.01%$70.4M$6.00M$781.7M
2023-06-305.94%$47.2M$15.20M$795.1M
2023-03-3112.06%$94.4M$14.00M$782.9M
2022-12-3120.77%$160M$35.20M$770.5M
2022-09-3031.22%$223.6M-$17.20M$716.2M
2022-06-3044.37%$337.7M$62.40M$761.1M
2022-03-3185.26%$380M$79.60M$445.7M
2021-09-3069.80%$414.8M$96.90M$594.3M

Annual ROI

DateROINet income 12 monthDebt plus equity
2025-09-3012.76%$95.4M$747.6M
2024-09-309.36%$78.3M$836.5M
2023-09-309.01%$70.4M$781.7M
2022-09-3031.22%$223.6M$716.2M
2021-09-3069.80%$414.8M$594.3M

Similar stocks

Stock NameCountryMarket CapPE Ratio
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
Orthofix Medical Inc. (OFIX)$0.373B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52